Class IIOngoing

Levothyroxine Sodium Tablets recall

FDA recall D-0259-2026 · initiated Dec 31, 2025

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.

Details

Product: Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.
Recalling company: Alvogen Inc
Classification: Class II
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: US Nationwide.
Initiated: Dec 31, 2025
FDA report date: Jan 21, 2026

This recall is linked to a product we cover: Thyro-Tabs →

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0259-2026 ↗

← All drug recalls